Search for a Medicine

  • Medicines
 
 

Showing 221-240 of 527 matching medicines

Product listings were last updated on 01/10/2020
Trade Name Licence Number & Holder Documents
REPLAGAL 1MG/ML
1mg/ml milligram(s)/millilitre Concentrate for solution for infusion

Compare
EU/1/01/189/001
Authorised: 03/08/2001
Shire Human Genetic Therapies AB
SPC PIL IPAR
REPSO
20 Milligram Film Coated Tablet

Compare
EU/1/11/674/006-010
Authorised: 14/03/2011
Teva B.V.
SPC PIL IPAR
Requip 0.25 mg film-coated tablets
0.25 milligram(s) Film-coated tablet

Compare
PA1077/037/001
Authorised: 03/12/1996
GlaxoSmithKline (Ireland) Limited
SPC PIL
Requip 1 mg film-coated tablets
1 milligram(s) Film-coated tablet

Compare
PA1077/037/003
Authorised: 03/12/1996
GlaxoSmithKline (Ireland) Limited
SPC PIL
Requip 2 mg film-coated tablets
2 milligram(s) Film-coated tablet

Compare
PA1077/037/004
Authorised: 03/12/1996
GlaxoSmithKline (Ireland) Limited
SPC PIL
Requip 5 mg film-coated tablets
5 milligram(s) Film-coated tablet

Compare
PA1077/037/005
Authorised: 03/12/1996
GlaxoSmithKline (Ireland) Limited
SPC PIL
Requip-Modutab 2 mg Prolonged-Release Tablets
2 milligram(s) Prolonged-release tablet

Compare
PA1077/037/006
Authorised: 01/02/2008
GlaxoSmithKline (Ireland) Limited
SPC PIL EdM
Requip-Modutab 2 mg Prolonged-Release Tablets
2 milligram(s) Prolonged-release tablet

Compare
PPA1562/115/001
Authorised: 20/06/2014
LTT Pharma Limited
SPC PIL
Requip-Modutab 2 mg Prolonged-Release Tablets
2 milligram(s) Prolonged-release tablet

Compare
PPA0465/279/002
Authorised: 20/09/2013
PCO Manufacturing Ltd.
SPC PIL
Requip-Modutab 4 mg Prolonged-Release Tablets
4 milligram(s) Prolonged-release tablet

Compare
PPA0465/279/003
Authorised: 20/09/2013
PCO Manufacturing Ltd.
SPC PIL
Requip-Modutab 4 mg Prolonged-Release Tablets
4 milligram(s) Prolonged-release tablet

Compare
PPA1562/115/002
Authorised: 20/06/2014
LTT Pharma Limited
SPC PIL
Requip-Modutab 4 mg prolonged-release tablets
4 milligram(s) Prolonged-release tablet

Compare
PPA2306/002/002
Authorised: 25/01/2019
Originalis B.V.
SPC PIL
Requip-Modutab 4 mg Prolonged-Release Tablets
4 milligram(s) Prolonged-release tablet

Compare
PA1077/037/008
Authorised: 01/02/2008
GlaxoSmithKline (Ireland) Limited
SPC PIL EdM
Requip-Modutab 8 mg Prolonged-Release Tablets
8 milligram(s) Prolonged-release tablet

Compare
PA1077/037/009
Authorised: 01/02/2008
GlaxoSmithKline (Ireland) Limited
SPC PIL EdM
Requip-Modutab 8 mg Prolonged-Release Tablets
8 milligram(s) Prolonged-release tablet

Compare
PPA1562/115/003
Authorised: 20/06/2014
LTT Pharma Limited
SPC PIL
Requip-Modutab 8 mg prolonged-release tablets
8 milligram(s) Prolonged-release tablet

Compare
PPA2306/002/001
Authorised: 23/11/2018
Originalis B.V.
SPC PIL
Requip-Modutab 8mg Prolonged-Release Tablets
8 milligram(s) Prolonged-release tablet

Compare
PPA0465/279/001
Authorised: 12/08/2011
PCO Manufacturing Ltd.
SPC PIL
Resolor
1 milligram(s) Film-coated tablet

Compare
EU/1/09/581/001

Shire Pharmaceuticals Ireland Limited
SPC PIL IPAR
Resolor
2 milligram(s) Film-coated tablet

Compare
EU/1/09/581/002

Shire Pharmaceuticals Ireland Limited
SPC PIL IPAR
Respreeza
1000 milligram(s) Powder and solvent for solution for injection

Compare
EU/1/15/1006/001

CSL Behring GmbH
SPC PIL IPAR